SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Baldo A, Sniderman AD, St-Luce S et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J Clin Invest 1993; 92: 15431547.
  • 2
    Cianflone K, Roncari DK, Maslowska M et al. The adipsin-acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis. Biochemistry 1994; 33: 94899495.
  • 3
    Yasruel Z, Cianflone K, Sniderman AD et al. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Lipids 1991; 26: 495499.
  • 4
    Haagsman HP, de Haas CM, Geelen MH, van Golde LG. Regulation of triacylglycerol synthesis in the liver modulation of diacylglycerol acyltransferase activity in vitro. J Biol Chem 1982; 257: 1059310598.
  • 5
    Germinario R, Sniderman AD, Manuel S et al. Coordinate regulation of the triacylglycerol synthesis and glucose transport by acylation stimulating protein. Metabolism 1993; 40: 574580.
  • 6
    Maslowska M, Sniderman AD, Germinario R, Cianflone K. ASP stimulates glucose transport in cultured human adipocytes. Int J Obes 1997; 21: 261266.
  • 7
    Tao YH, Cianflone K, Sniderman AD, Colby-Germinario SP, Germinario RJ. Acylation-stimulating protein (ASP) regulates glucose transport in the rat L6 muscle cell line. Biochim Biophys Acta 1997; 1344: 221229.
  • 8
    Sniderman AD, Maslowska M, Cianflone K. Of mice and men (and women) and the acylation-stimulating protein pathway. Curr Opin Lipidol 2000; 11: 291296.
  • 9
    Scantlebury T, Maslowska M, Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 1998; 273: 2090320909.
  • 10
    Saleh J, Summers LKM, Cianflone K et al. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 1998; 39: 884891.
  • 11
    Cianflone K, Zakarian R, Couillard C et al. Fasting acylation-stimulating protein is predictive of postprandial triglyceride clearance. J Lipid Res 2004; 45: 124131.
  • 12
    Murray IA, Sniderman AD, Cianflone K. Enhanced triglyceride clearance with intraperitoneal human acylation stimulating protein (ASP) in C57Bl/6 mice. Am J Physiol Endocrinol Metab 1999; 277: E474E480.
  • 13
    Saleh J, Blevins JE, Havel PJ et al. Acylation stimulating protein (ASP) acute effects on postprandial lipemia and food intake in rodents. Int J Obes Relat Metab Disord 2001; 25: 705713.
  • 14
    Murray I, Sniderman AD, Havel PJ, Cianflone K. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. J Biol Chem 1999; 274: 3621936225.
  • 15
    Xia Z, Sniderman AD, Cianflone K. Acylation-stimulating protein (ASP) deficiency induces obesity resistance and increased energy expenditure in ob/ob mice. J Biol Chem 2002; 277: 4587445879.
  • 16
    Maslowska M, Vu H, Phelis S et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur J Clin Invest 1999; 29: 679686.
  • 17
    Cianflone K, Sniderman AD, Kalant D, Marliss EB, Gougeon R. Response of plasma ASP to a prolonged fast. Int J Obesity 1995; 19: 604609.
  • 18
    Sniderman AD, Cianflone K, Eckel RH. Levels of acylation stimulating protein in obese women before and after moderate weight loss. Int J Obesity 1991; 15: 333336.
  • 19
    Cianflone K, Lu H, Smith J, Yu W, Wang H. Adiponectin, acylation stimulating protein and complement C3 are altered in obesity in very young children. Clin Endocrinol 2005; 62: 567572.
  • 20
    Koistinen HA, Koivisto VA, Andersson S et al. Leptin concentration in cord blood correlates with intrauterine growth. J Clin Endocrinol Metab 1997; 82: 33283330.
  • 21
    Sivan E, Mazaki-Tovi S, Pariente C et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. J Clin Endocrinol Metab 2003; 88: 56565660.
  • 22
    Kitamura S, Yokota I, Hosoda H et al. Ghrelin concentration in cord and neonatal blood: relation to fetal growth and energy balance. J Clin Endocrinol Metab 2003; 88: 54735477.
  • 23
    Ong K, Kratzsch J, Kiess W et al. Size at birth and cord blood levels of insulin, insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-1 (IGFBP-1), IGFBP-3, and the soluble IGF-II/mannose-6-phosphate receptor in term human infants. J Clin Endocrinol Metab 2000; 85: 42664269.
  • 24
    Kirimi E, Cesur Y, Gül A. Normal levels of insulin, growth hormone and cortisol levels in venous cord blood of healthy full-term infants: correlation with birthweight and placental weight. East J Med 2001; 6: 1417.
  • 25
    Blackburn ST, Loper DL. Carbohydrate, fat, and protein metabolism. In: Eoyang T (ed). Maternal, Fetal and Neonatal Physiology: A clinical Perspective. W.B. Saunders: Philadelphia, PA, 1992, pp 583613.
  • 26
    Brown MB, Forsythe AB. Robust test for the equality of variances. J Am Stat Assoc 1974; 69: 364367.
  • 27
    Levene H. Robust tests for equality of variances. In: Olkin I, Ghurye SG, Hoeffding W, Madow WG, Mann HB (eds). Contributions of Probability and Statistics: Essays in Honor of Harold Hotelling. Stanford University Press: Menlo Park, CA, 1960, pp 278292.
  • 28
    Contois J, Lammi-Keefe C, Vogel S et al. Plasma lipoprotein(a) distribution in the Framingham Offspring Study as determined with a commercially available immunoturbidimetric assay. Clin Chim Acta 1996; 253: 2135.
  • 29
    Painter P, Cope J, Smith J. Reference information for the clinical laboratory. In: Burtis C, Ashwood E (eds). Tietz Text Book of Clinical Chemistry, 3rd edn. W.B. Saunders: Philadelphia, PA, 1999, p1799.
  • 30
    Saleh J, Cianflone K, Chaudhary T et al. Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity (Silver Spring) 2007; 15: 646652.
  • 31
    Magnusson-Olsson AL, Hamark B, Ericsson A et al. Gestational and hormonal regulation of human placental lipoprotein lipase. J Lipid Res 2006; 47: 25512561.
  • 32
    Magnusson A, Waterman I, Wennergren M, Jansson T, Powell T. Triglyceride hydrolase activities and expression of fatty acid binding proteins in the human placenta in pregnancies complicated by intrauterine growth restriction and diabetes. J Clin Endocrinol Metab 2004; 89: 46074614.
  • 33
    Knopp RH, Bonet B, Zhu X. Lipid metabolism in pregnancy. In: Cowett RM (ed). Principles of Perinatal-neonatal Metabolism 2nd edn. Springer: New York, 1988, pp 221258.
  • 34
    Kitajima M, Oka S, Yasuhi I et al. Maternal serum triglyceride at 24–32 weeks' gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 2001; 97: 776780.
  • 35
    Di Cianni G, Miccoli R, Volpe L et al. Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 2005; 22: 2125.
  • 36
    Pardo IM, Geloneze B, Tambascia MA, Barros-Filho AA. Hyperadiponectinemia in newborns: relationship with leptin levels and birth weight. Obesity Res 2004; 12: 521524.
  • 37
    Wolf HJ, Ebenbichler CF, Huter O et al. Fetal leptin and insulin levels onlycorrelate in large-for-gestational age infants. Eur J Endocrinol 2000; 142: 623629.
  • 38
    Scantlebury T, Maslowska M, Cianflone K. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 1998; 273: 2090320909.
  • 39
    Scantlebury T, Sniderman AD, Cianflone K. Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J 2001; 356: 445452.
  • 40
    Quadro L, Hamberger L, Gottesman ME et al. Transplacental delivery of retinoid: the role of retinol-binding protein and lipoprotein retinyl ester. Am J Physiol Endocrinol Metab 2004; 286: E844E851.